These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6292911)

  • 1. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
    Kozbor D; Lagarde AE; Roder JC
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6651-5. PubMed ID: 6292911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
    Chiorazzi N; Wasserman RL; Kunkel HG
    J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
    Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
    Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of ouabain-resistant human fusion partners.
    Ramachandra RN; Berczi I; Rector ES; Sehon AH
    J Immunol Methods; 1991 Aug; 142(1):21-9. PubMed ID: 1655911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibodies against Mycobacterium leprae.
    Atlaw T; Kozbor D; Roder JC
    Infect Immun; 1985 Jul; 49(1):104-10. PubMed ID: 2989177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
    Glasky MS; Reading CL
    Hybridoma; 1989 Aug; 8(4):377-89. PubMed ID: 2550358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human hybridomas secreting antibody to tetanus toxoid.
    Larrick JW; Truitt KE; Raubitschek AA; Senyk G; Wang JC
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6376-80. PubMed ID: 6578513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of a human monoclonal antibody to HLA by human-human hybridoma technology. A preliminary report.
    Hulette CM; Effros RB; Dillard LC; Walford RL
    Am J Pathol; 1985 Oct; 121(1):10-4. PubMed ID: 2996358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
    J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.
    Glassy MC; Handley HH; Hagiwara H; Royston I
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6327-31. PubMed ID: 6604917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
    Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
    Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of human-human and human-mouse hybridomas secreting Rh(D)-specific monoclonal antibodies.
    MacDonald G; Primrose S; Biggins K; Bowman JM; Berczi I; Friesen AD; Sehon AH
    Scand J Immunol; 1987 May; 25(5):477-83. PubMed ID: 3035706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro stimulated lymphocytes as a source of human hybridomas.
    Kozbor D; Roder JC
    Eur J Immunol; 1984 Jan; 14(1):23-7. PubMed ID: 6319153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.